Tarzana, CA, United States of America

Lynn K Gordon

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 71(Granted Patents)


Company Filing History:


Years Active: 2004-2017

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Innovations by Inventor Lynn K. Gordon

Introduction

Lynn K. Gordon, based in Tarzana, California, is an esteemed inventor known for his significant contributions to the field of biomedical sciences. With a total of eight patents to his name, Gordon's innovations focus primarily on the treatment and prevention of infections and cancer through novel approaches targeting epithelial membrane proteins.

Latest Patents

Among his notable inventions, Gordon's recent patents include groundbreaking methods and compositions that provide solutions for treating infections and cancer. One of his latest patents involves antibodies that bind to epithelial membrane protein 2 (EMP2). This invention inhibits the entry of harmful agents into host cells expressing EMP2, thereby interfering with the interaction that leads to infection. Furthermore, this technology specifically targets cancers that express or overexpress EMP2 nucleic acids and polypeptides.

Another of his significant patents addresses proliferative vitreoretinopathy (PVR), offering methods to prevent retinal detachment. This invention involves administering agents that antagonize the activity of EMP2 to individuals at risk, highlighting the therapeutic potential of his research in ophthalmology.

Career Highlights

Throughout his career, Lynn K. Gordon has collaborated with prestigious institutions such as the University of California and the United States Government, as represented by the Department of Veterans Affairs. His work has not only contributed to scientific advancements but has also displayed a commitment to practical applications in healthcare.

Collaborations

Gordon has had the opportunity to work alongside distinguished colleagues, including Jonathan Braun and Anna M. Wu. Their collaboration reflects a shared vision in advancing medical research and developing innovative treatments that can significantly impact patient outcomes.

Conclusion

Lynn K. Gordon's contributions to science through his patents exemplify the essence of innovation in medicine. His focused research on EMP2 and related therapies underscores the relevance of targeted treatments in addressing complex health issues. As a dedicated inventor, Gordon continues to inspire future innovations in the biomedical field, paving the way for advancements that could change lives.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…